Roderick C.N. van den Bergh
St. Antonius Ziekenhuis, The Netherlands Cancer Institute, University Medical Center Utrecht, Erasmus MC
Papers
12
Total Citations
224
H-Index
9
About
Roderick C.N. van den Bergh is a urological oncologist and clinical researcher whose work centers on the diagnosis, surgical management, and quality-of-life outcomes of prostate cancer. With a career spanning over a decade of impactful scholarship, van den Bergh has made substantial contributions to several intersecting areas: focal ablative therapy, nerve-sparing radical prostatectomy, advanced imaging with PSMA PET/CT, and patient-reported outcomes research. His systematic review on focal ablative therapy (52 citations) has become an authoritative reference for clinicians navigating treatment decisions for localized prostate cancer, while his earlier work comparing interview-based and questionnaire-based quality-of-life assessments (32 citations) offered nuanced insights into measuring patient experience in routine clinical practice. His research on nerve-sparing robot-assisted radical prostatectomy and the impact of active surveillance on subsequent quality of life highlights his sustained commitment to patient-centered care. More recently, van den Bergh has positioned himself at the forefront of precision oncology by investigating PSMA PET/CT imaging for both local staging and salvage radiation therapy planning, incorporating artificial intelligence-driven MRI models to better predict extraprostatic extension. Collectively, his body of work reflects a rigorous, translational approach that bridges advanced technology with meaningful clinical and quality-of-life outcomes for prostate cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10